Chantal Heron

Chantal Heron is an experienced regulatory affairs professional currently serving as Associate Director of Regulatory Affairs at Nuvation Bio, following the acquisition of AnHeart Therapeutics. Previous roles include Associate Director at AnHeart Therapeutics, where responsibilities encompassed managing regulatory operations and overseeing various submissions such as INDs and NDAs. Chantal has held senior regulatory positions at Ambrx and Chugai Pharma USA, Inc., focusing on high-quality regulatory submissions and compliance. Additional experience includes roles at Array BioPharma, Daiichi Sankyo, Eisai, IKARIA, Janssen, and Pfizer, specializing in regulatory submissions, clinical publishing, and collaboration with global regulatory teams. Chantal is pursuing a Master's degree in Public Health Education and Promotion at Walden University and holds a Bachelor of Arts in English Writing Arts from the State University of New York at Oswego.